Children with ADHD and tic disorder and their classmates: behavioral normalization with methylphenidate

Area of Science:

• Child and Adolescent Psychiatry
• Neurodevelopmental Disorders
• Pharmacology

Background:

• Attention-deficit hyperactivity disorder (ADHD) and tic disorders frequently co-occur in children.
• Behavioral challenges in children with ADHD and tics can impact academic and social functioning.
• Methylphenidate is a common stimulant medication used to manage ADHD symptoms.

Purpose of the Study:

• To compare behavioral differences between children with ADHD and tics and their peers.
• To evaluate the normalizing effect of methylphenidate on the behavior of children with ADHD and tics.
• To investigate potential indirect effects of methylphenidate treatment on peer behavior (treatment spillover).

Main Methods:

• Observational study of 34 prepubertal children with ADHD and chronic tic disorder and their peers.
• Data collected over approximately 20 hours in various school settings.
• Double-blind, placebo-controlled methylphenidate evaluation with varying dosages (0.1, 0.3, 0.5 mg/kg).

Main Results:

• Children with ADHD and tics exhibited significantly more inattentive, disruptive, and aggressive behaviors than peers.
• Methylphenidate reduced the distinction between probands and peers, but complete normalization was not achieved at the highest dose.
• No significant evidence of methylphenidate treatment spillover effects on peer behavior was observed.

Conclusions:

• Conventional methylphenidate doses significantly improve ADHD-related behaviors in children with comorbid tics.
• Complete behavioral normalization in children with ADHD and tics receiving methylphenidate is not consistently achieved.
• Further research may be needed to optimize treatment strategies for this population.